1.35%| Prev Close: | 1.52 |
|---|---|
| Open: | 1.54 |
| Bid: | 0.86 x 15000 |
| Ask: | 1.56 x 300 |
| 1y Target Est: | 1.75 |
| Beta: | 1.17 |
| Next Earnings Date: | N/A |
| Day's Range: | 1.47 - 1.54 |
|---|---|
| 52wk Range: | 0.70 - 1.79 |
| Volume: | 11,600 |
| Avg Vol (3m): | 38,388 |
| Market Cap: | 49.20M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.19 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CFO Moves: Response Genetics, Waterlogic, Feroniaat The Wall Street Journal(Mon, Jun 17)
- RESPONSE GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitEDGAR Online(Mon, Jun 17)
- Response Genetics Achieves Milestone Payments Totaling $1,000,000 for Services Provided to GlaxoSmithKline in the Development of BRAF-Inhibitor Tafinlar(R) (dabrafenib)GlobeNewswire(Tue, Jun 4)
- RESPONSE GENETICS INC FinancialsEDGAR Online Financials(Tue, May 21)
- Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology 2013 Annual MeetingGlobeNewswire(Mon, May 20)
- Response Genetics, Inc. Announces Contract With Blue Shield of CaliforniaGlobeNewswire(Thu, May 16)
- Emerging Biomarker Companies Redux: Positioned For Growthat Seeking Alpha(Wed, May 15)
- RESPONSE GENETICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- Response Genetics' CEO Discusses F1Q13 Earnings Results - Earnings Call Transcriptat Seeking Alpha(Tue, May 14)
- Q1 2013 Response Genetics Earnings Release - Before Market OpenCCBN(Tue, May 14)
- Response Genetics, Inc. Announces First Quarter 2013 Financial ResultsGlobeNewswire(Tue, May 14)
- RESPONSE GENETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhEDGAR Online(Tue, May 14)
- Response Genetics to Present at the 2013 UBS Global Healthcare ConferenceGlobeNewswire(Wed, May 8)
- Response Genetics, Inc. to Release First Quarter 2013 Financial Results and Host Conference Call on May 14, 2013GlobeNewswire(Mon, May 6)
- RESPONSE GENETICS INC Files SEC form 10-K, Annual ReportEDGAR Online(Wed, Mar 27)
Press Releases
- Response Genetics Achieves Milestone Payments Totaling $1,000,000 for Services Provided to GlaxoSmithKline in the Development of BRAF-Inhibitor Tafinlar(R) (dabrafenib)GlobeNewswire(Tue, Jun 4)
- Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology 2013 Annual MeetingGlobeNewswire(Mon, May 20)
- Response Genetics, Inc. Announces Contract With Blue Shield of CaliforniaGlobeNewswire(Thu, May 16)
Reports
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(Jun 19)
- Wright Investors Service Comprehensive Report for Response Genetics, Inc.Wright Reports(Jun 16)
- RESPONSE GENETICS INC (RGDX) 12-months forecastPechala's Reports(Jun 15)